(Total Views: 751)
Posted On: 11/01/2020 10:09:19 AM
Post# of 154754
Re: onestepahead #63915
Who Will Enroll vs SOC?
So doctor says to a s/c patient, do you want remdesivir IV and plasma, or a 2/3 chance of getting an experimental drug called leronlimab, which has shown a lot of promise in clinical trials?
The educated patient may choose our s/c trial???
Enrollment in our Phase III s/c trial, would be most appealing to a patient who has already received SOC, and then after, remains in s/c condition.
After full enrollment, then we wait 42 days for the last injected patient to live or die, then wait a couple of weeks for Interim analysis. A lot of waiting and a lot of global deaths, many many, between now and then.
FDA should look at our 195 interim data and approve!!!!
So doctor says to a s/c patient, do you want remdesivir IV and plasma, or a 2/3 chance of getting an experimental drug called leronlimab, which has shown a lot of promise in clinical trials?
The educated patient may choose our s/c trial???
Enrollment in our Phase III s/c trial, would be most appealing to a patient who has already received SOC, and then after, remains in s/c condition.
After full enrollment, then we wait 42 days for the last injected patient to live or die, then wait a couple of weeks for Interim analysis. A lot of waiting and a lot of global deaths, many many, between now and then.
FDA should look at our 195 interim data and approve!!!!
(2)
(0)
